COMPARISON OF A NOVEL, LABEL-FREE, AND REAL-TIME CELL BASED SYSTEM (XCELLIGENCE) WITH A CONVENTIONAL VIABILITY ASSAY (XTT) TO DETERMINE THE ANTI-PROLIFERATIVE EFFECT OF AT-101 IN HUMAN BREAST CANCER CELLS

dc.contributor.authorKaraca, B
dc.contributor.authorAtmaca, H
dc.contributor.authorAsli, K
dc.contributor.authorBozkurt, E
dc.contributor.authorCakar, B
dc.contributor.authorSurmeli, ZG
dc.contributor.authorGursoy, P
dc.contributor.authorKarabulut, B
dc.contributor.authorUzunoglu, S
dc.contributor.authorSezgin, C
dc.date.accessioned2024-07-18T11:51:55Z
dc.date.available2024-07-18T11:51:55Z
dc.identifier.issn0923-7534
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/5242
dc.language.isoEnglish
dc.publisherOXFORD UNIV PRESS
dc.titleCOMPARISON OF A NOVEL, LABEL-FREE, AND REAL-TIME CELL BASED SYSTEM (XCELLIGENCE) WITH A CONVENTIONAL VIABILITY ASSAY (XTT) TO DETERMINE THE ANTI-PROLIFERATIVE EFFECT OF AT-101 IN HUMAN BREAST CANCER CELLS
dc.typeMeeting Abstract

Files